“One Pfizer” Restructuring Initiative Divides R&D And Sales Operations
Executive Summary
Pfizer's latest corporate restructuring represents a shift away from its recent alignment of research & development and commercialization operations
You may also be interested in...
Roche Re-Models Around Disease Areas, Pulls Together R&D And Commercial
Roche is taking a dual approach in reorganizing its global R&D business by centering on key disease areas and consolidating its full operations, from R&D to marketing, along those lines
Roche Re-Models Around Disease Areas, Pulls Together R&D And Commercial
Roche is taking a dual approach in reorganizing its global R&D business by centering on key disease areas and consolidating its full operations, from R&D to marketing, along those lines
Roche Re-Models Around Disease Areas, Pulls Together R&D And Commercial
Roche is taking a dual approach in reorganizing its global R&D business by centering on key disease areas and consolidating its full operations, from R&D to marketing, along those lines